RecruitingPhase 3NCT06739122
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Sponsor: Eli Lilly and Company
Denver, CO · +40 more sites
2 recruiting type 2 diabetes studies with a site in Denver, CO.
Sponsor: Eli Lilly and Company
Denver, CO · +40 more sites
Sponsor: Scripps Whittier Diabetes Institute
Denver, CO · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.